Egalet ^{Priced, Nasdaq: EGLT}

Developing abuse-deterrent oral products for the treatment of pain.

Industry: Health Care

First Day Return: 0.0%

EGLT

Developing abuse-deterrent oral products for the treatment of pain.

IPO News for Egalet

US IPO Recap: Revance jumps 68% in ten-IPO week 02/10/14
Egalet prices upsized IPO at $12, the midpoint of the $11 to $13 range 02/06/14
12 US IPOs planned for the week of Feb 3 02/03/14

IPO Data
IPO Date	02/05/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$50
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Malvern, PA, United States
Founded	2010
Employees at IPO	18
Website www.egalet.com

IPO News for Egalet

US IPO Recap: Revance jumps 68% in ten-IPO week 02/10/14
Egalet prices upsized IPO at $12, the midpoint of the $11 to $13 range 02/06/14
12 US IPOs planned for the week of Feb 3 02/03/14

Egalet (EGLT) Performance